Japer Therapeutics Warrants
JSPRW
26 hedge funds and large institutions have $2.51M invested in Japer Therapeutics Warrants in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 13 closing their positions.
26% less funds holding
Funds holding: 35 → 26 (-9)
50% less capital invested
Capital invested by funds: $4.99M → $2.51M (-$2.48M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$263K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$256K |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$14.6K |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
+$2.38K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$88 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$246K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$236K |
| 3 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$183K |
| 4 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$112K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAMP
26
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$236K | -162,500 | Closed |
|
|
BCM
27
Beryl Capital Management
Redondo Beach,
California
| – | -$183K | -126,204 | Closed |
|
|
LIM
28
Longfellow Investment Management
Boston,
Massachusetts
| – | -$112K | -75,531 | Closed |
|
|
29
Verition Fund Management
Greenwich,
Connecticut
| – | -$81K | -56,001 | Closed |
|
|
AIMCA
30
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
| – | -$54K | -37,000 | Closed |
|
31
Walleye Capital
New York
| – | -$48 | -33,410 | Closed |
|
|
BFM
32
Boothbay Fund Management
New York
| – | -$246K | -24,622 | Closed |
|
33
Walleye Trading
New York
| – | -$30K | -20,790 | Closed |
|
|
BCM
34
Basso Capital Management
Stamford,
Connecticut
| – | -$26K | -18,245 | Closed |
|
|
CAC
35
Cowen and Company
New York
| – | -$22K | -15,000 | Closed |
|
36
Geode Capital Management
Boston,
Massachusetts
| – | -$20K | -14,000 | Closed |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -372 | Closed |
|
|
WAM
38
Wolverine Asset Management
Chicago,
Illinois
| – | +$88 | +60 | New |
|
JSPRW Hedge Fund Activity: Q1 2021 in Review
26 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2021, worth a combined $2.51M — down 50% from $4.99M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of JSPRW and 4 opened new positions — a net loss of 9 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $263K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $246K sold.
- 26 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2021, down from 35 in Q4 2020.
- Funds reported $2.51M of Japer Therapeutics Warrants stock for Q1 2021, down 50% quarter-over-quarter.
- 4 funds opened new Japer Therapeutics Warrants positions in Q1 2021 and 13 closed out, a net change of -9 holders.
- The largest Japer Therapeutics Warrants buyer in Q1 2021 was UBS O'Connor, an estimated $263K added.
- The largest Japer Therapeutics Warrants seller in Q1 2021 was Boothbay Fund Management, an estimated $246K sold.
Based on aggregated 13F filings for Q1 2021.